Jaguar Health today announced it has secured a $240,000 FDA grant to advance research on a treatment for chemotherapy-induced diarrhea in dogs, a serious and often dangerous side effect of cancer care...
AstraZeneca today announced positive phase III clinical data for baxdrostat, an investigational oral therapy being developed for patients with uncontrolled or resistant hypertension. The results strengthen baxdrostat’s position as a potential...
Torrent Pharma approves Rs 12,500 crore NCD issue to boost liquidity, fund acquisitions and capex, while maintaining strong balance sheet, low leverage, and long-term growth focus.
Intelligent Bio Solutions has entered a major global manufacturing partnership with Syrma Johari MedTech Ltd, a move set to sharply reduce costs, improve margins, and speed up its planned US market entry. Announced today, the agreement...
Hindustan Laboratories has filed IPO papers with SEBI, preparing for its market debut and signaling a strategic move to expand operations in India’s fast?growing generic drug market. The submission is made at a time when there is still a high...
Strides has made a decisive leadership move to speed up Strides Digital Transformation, appointing Yajuvendra Singh M R as Vice President of Digital Transformation. The appointment, announced today, signals the company’s sharper focus on using...
Semaglutide patent expiry is set to open a Rs 50 billion generic drug opportunity, boosting pharma revenues across India, regulated markets and emerging economies.
The Union Health Ministry is in discussions with state governments on the possibility of granting additional time to certain pharmaceutical manufacturers to comply with revised Good Manufacturing Practices (GMP) norms under Schedule M of the Drug...
Health ministry bans oral nimesulide above 100 mg for human use after DTAB and ICMR review, citing safety risks, second-line therapy use, and safer drug alternatives.
Dr. Reddy’s Labs receives a USFDA CRL for AVT03 denosumab biosimilar, citing manufacturing inspection issues, delaying approval in the key US biologics market.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")